68Ga-FAPI与18F-FDG PET/CT在新诊断乳腺癌患者评估中的头对头对比研究
该前瞻性研究纳入34例新诊断乳腺癌女性,均在1周内完成68Ga-FAPI与18F-FDG PET/CT。68Ga-FAPI在原发灶SUVmax和靶本比上高于18F-FDG,其SUVmax与病理分级和最终分期正相关;68Ga-FAPI诊断淋巴结转移的特异度和准确度更高,N分期和N0腋窝状态评估准确度也更高。
要点
- 68Ga-FAPI原发灶SUVmax和靶本比均高于18F-FDG。
- 68Ga-FAPI SUVmax与病理分级和最终分期正相关。
- 68Ga-FAPI评估N分期和N0腋窝状态准确度高于18F-FDG。
核心结论
- 68Ga-FAPI PET/CT评估N分期尤其是N0腋窝状态的准确度高于18F-FDG,有助于改善乳腺癌患者的治疗策略。
- 68Ga-FAPI SUVmax与原发性病灶的病理分级和患者最终分期呈正相关。
研究设计与样本
- 前瞻性纳入34例新诊断乳腺癌女性,均在1周内接受68Ga-FAPI和18F-FDG PET/CT检查。
- 比较两种PET/CT对原发灶的影像特征、淋巴结转移的诊断效能及N分期评估的准确度。
主要发现
- 68Ga-FAPI原发灶SUVmax为11.06 ± 5.48,18F-FDG为8.33 ± 6.07,P = 0.02。
- 68Ga-FAPI原发灶靶本比为15.32 ± 10.33,18F-FDG为8.25 ± 5.51,P < 0.001。
- 68Ga-FAPI SUVmax与原发性病灶病理分级及患者最终分期呈正相关(P < 0.001)。
- 基于患者和基于病灶分析中,68Ga-FAPI诊断淋巴结转移的特异度和准确度均高于18F-FDG(P < 0.001)。
- N分期评估准确度68Ga-FAPI为91.2%(31/34),18F-FDG为73.5%(25/34);N0腋窝状态评估准确度68Ga-FAPI为85.7%(12/14),18F-FDG为42.9%(6/14)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to compare the performance of 68Ga-FAPI and 18F-FDG PET/CT in the evaluation of patients with newly diagnosed breast cancer. METHODS: Thirty-four women with newly diagnosed breast cancer who underwent both 68Ga-FAPI and 18F-FDG PET/CT within 1 week were prospectively included in the study. The imaging characteristics of primary lesions, diagnostic efficiency of lymph node metastasis (LNM), and accuracy of N stage evaluation between 2 PET/CTs were compared. RESULTS: 68Ga-FAPI showed higher SUVmax (11.06 ± 5.48 vs 8.33 ± 6.07, P = 0.02) and tumor-to-background ratio (15.32 ± 10.33 vs 8.25 ± 5.51, P < 0.001) than 18F-FDG in primary tumors. 68Ga-FAPI SUVmax was positively correlated with the pathological grade of the primary lesions and the final stage of the patients (P < 0.001). The specificity and accuracy of 68Ga-FAPI was higher than that of 18F-FDG in the diagnosis of LNMs on patient-based and lesion-based analysis (P < 0.001). The accuracy for the evaluation of N stage and N0 axillar status was 91.2% (31/34) and 85.7% (12/14) for 68Ga-FAPI, and 73.5% (25/34) and 42.9% (6/14) for 18F-FDG, respectively. CONCLUSIONS: The 68Ga-FAPI SUVmax was positively correlated with the pathological grade of the primary lesions and the final stage of the patients. 68Ga-FAPI PET/CT has higher accuracy than 18F-FDG in the evaluation of N stage, especially N0 axillar status, which is helpful to improve the treatment strategy for breast cancer patients.
引用
- Zheng S, Lin J, Zhu Y, et al. 68Ga-FAPI Versus 18F-FDG PET/CT in Evaluating Newly Diagnosed Breast Cancer Patients: A Head-to-Head Comparative Study. Clin Nucl Med. 2023. PMID: 36723892. doi:10.1097/RLU.0000000000004523
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。